[Ip-health] New publication: The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam

Deborah Gleeson deborah at gleeson.net
Mon Nov 14 04:01:09 PST 2016

Hazel V. J. Moir, Brigitte Tenni, Deborah Gleeson & Ruth Lopert (2016): The
Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam,
Global Public Health, DOI: 10.1080/17441692.2016.1256418

50 free copies are available at:



In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA
successfully pursued intellectual property (IP) provisions that will affect
the affordability of medicines, including anti-retrovirals (ARV) for HIV.
Vietnam has the lowest GDP per capita of the 12 TPP countries and in 2013
provided ARVs for only 68% of eligible people living with HIV. Using the
current Vietnamese IP regime as our base case, we analysed the potential
impact of a regime making full use of legal IP flexibilities, and one based
on the IP provisions of the final, agreed TPP text. Results indicate that
at current funding levels 82% of Vietnam’s eligible people living with HIV
would receive ARVs if legal flexibilities were fully utilised, while as few
as 30% may have access to ARVs under the TPP Agreement – more than halving
the proportion currently treated.

Deborah Gleeson MPH PhD
School of Psychology and Public Health
La Trobe University VIC 3086

National Convener
Political Economy of Health Special Interest Group
Public Health Association of Australia

T: +61 3 9479 3262
M: +61 423 209029

More information about the Ip-health mailing list